Real-time enrollment status for this acute myelogenous leukemia clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 6:03 PM UTC
| NCT Number | NCT06656494 |
| Recruiting Status | Recruiting |
| Condition | Acute Myelogenous Leukemia |
| Phase | PHASE1 |
| Target Enrollment | 266 participants |
| Active Locations | 6 sites in the US |
| Sponsor | Beijing InnoCare Pharma Tech Co., Ltd. |
| Last Updated on CT.gov | August 18, 2026 (2 weeks ago) |
As of September 1, 2026: Clinical trial NCT06656494 is currently recruiting participants. This phase1 study for acute myelogenous leukemia is actively seeking new participants at 6 locations across the United States. The study is sponsored by Beijing InnoCare Pharma Tech Co., Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06656494 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06656494 was last updated 2 weeks ago (August 18, 2026). HelloStudys verifies this status automatically.